Spots Global Cancer Trial Database for skin diseases
Every month we try and update this database with for skin diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease | NCT04711252 | ER-Positive HER... | AZD9833 Anastrozole Anastrozole pla... AZD9833 placebo Palbociclib Luteinizing hor... | 18 Years - 130 Years | AstraZeneca | |
| Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer | NCT04138342 | Breast Cancer Skin Cancer Skin Diseases | Quantum dots co... Topical approve... | 25 Years - 60 Years | Al-Azhar University | |
| Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI | NCT01425749 | Melanoma | recMAGE-A3 + AS... | 18 Years - | University of Virginia | |
| Studying Normal Breast Tissue and Cancer Risk | NCT00341692 | Breast Neoplasm... Neoplasms by Si... Neoplasms Breast Diseases Skin Diseases | 11 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Non-Linear Imaging of Skin In Vivo | NCT05410964 | Skin Cancer Skin Condition Skin Diseases Skin Lesion Skin Abnormalit... | VIO System | 2 Years - 90 Years | Enspectra Health | |
| Non-Linear Imaging of Skin In Vivo | NCT05410964 | Skin Cancer Skin Condition Skin Diseases Skin Lesion Skin Abnormalit... | VIO System | 2 Years - 90 Years | Enspectra Health | |
| Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070) | NCT01567813 | Human Papilloma... | 9 Years - 26 Years | Merck Sharp & Dohme LLC | ||
| Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC | NCT01917279 | Breast Neoplasm... Neoplasms by Si... Neoplasm Metast... Breast Diseases Skin Diseases | Docetaxel plus ... Intermittent Ca... Metronomic Cape... | 18 Years - | ChineseAMS | |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
| A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System | NCT05463523 | Skin Diseases Artificial Inte... Augmented Reali... Medical Imaging | A Real-time Aug... | - | Xiangya Hospital of Central South University | |
| The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction | NCT01427400 | Breast Neoplasm... Neoplasms by Si... Neoplasms Breast Diseases Skin Diseases | Botulinum Toxin... Saline | 21 Years - | University of British Columbia | |
| Microwave Treatment for Actinic Keratosis | NCT05636800 | Keratosis, Acti... | Swift System | 18 Years - 85 Years | Blackwell Device Consulting | |
| Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer | NCT04138342 | Breast Cancer Skin Cancer Skin Diseases | Quantum dots co... Topical approve... | 25 Years - 60 Years | Al-Azhar University | |
| VIO Imaging for Skin Tissue Assessment (VISTA) | NCT05619471 | Skin Condition Skin Diseases Skin Lesion Skin Abnormalit... Skin Cancer | VIO Imaging | 18 Years - 99 Years | Enspectra Health | |
| A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer | NCT00050427 | Breast Neoplasm... Neoplasms Neoplasms by Si... Breast Diseases Skin Diseases | ET743 ET743 | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Artificial Intelligence Patient App for RDEB SCCs | NCT05843994 | Epidermolysis B... | online survey | 12 Years - | Northwestern University | |
| A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp | NCT03285477 | Actinic Keratos... | Placebo KX2-391 Ointmen... | 18 Years - | Almirall, S.A. | |
| Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI | NCT01425749 | Melanoma | recMAGE-A3 + AS... | 18 Years - | University of Virginia | |
| EndoPredict® Extended Endocrine Trial (EXET) | NCT04016935 | Primary Invasiv... | Observational | 18 Years - | Myriad Genetic Laboratories, Inc. | |
| Cantharidin and Occlusion in Verruca Epithelium | NCT03487549 | Common Wart Warts Hand Warts Papillomavirus ... DNA Virus Infec... Skin Diseases, ... Skin Diseases, ... Skin Diseases Virus Diseases Tumor Virus Inf... Verruca Vulgari... Verruca | VP-102 Canthari... VP-102 Canthari... | 2 Years - | Verrica Pharmaceuticals Inc. | |
| Lymphaticovenous Anastomosis as Treatment for Lymphedema | NCT05441943 | Breast Cancer L... Secondary Lymph... Iatrogenic Lymp... Lymphedema Lymphedema of U... Lymphedema Arm Lymphedema, Bre... Breast Neoplasm Neoplasms Breast Cancer Breast Diseases Lymphatic Disea... Skin Diseases Postoperative C... Pathologic Proc... Anastomose Surgery Surgical; Lymph... Postmastectomy ... Postmastectomy ... Postmastectomy ... Postmastectomy ... | Lymphovenous an... | 18 Years - | Odense University Hospital | |
| Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population | NCT01598779 | Condylomata Acu... | 15 Years - 45 Years | University of Buenos Aires | ||
| Lymphaticovenous Anastomosis as Treatment for Lymphedema | NCT05441943 | Breast Cancer L... Secondary Lymph... Iatrogenic Lymp... Lymphedema Lymphedema of U... Lymphedema Arm Lymphedema, Bre... Breast Neoplasm Neoplasms Breast Cancer Breast Diseases Lymphatic Disea... Skin Diseases Postoperative C... Pathologic Proc... Anastomose Surgery Surgical; Lymph... Postmastectomy ... Postmastectomy ... Postmastectomy ... Postmastectomy ... | Lymphovenous an... | 18 Years - | Odense University Hospital | |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
| (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | NCT04996875 | Advanced System... SM With an Asso... Mast Cell Leuke... Aggressive Syst... | bezuclastinib | 18 Years - | Cogent Biosciences, Inc. | |
| A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System | NCT05463523 | Skin Diseases Artificial Inte... Augmented Reali... Medical Imaging | A Real-time Aug... | - | Xiangya Hospital of Central South University | |
| Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population | NCT01598779 | Condylomata Acu... | 15 Years - 45 Years | University of Buenos Aires | ||
| Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer | NCT03818620 | Skin Cancer Skin Diseases | Barco digital d... Reference stand... | 18 Years - | Barco NV | |
| EndoPredict® Extended Endocrine Trial (EXET) | NCT04016935 | Primary Invasiv... | Observational | 18 Years - | Myriad Genetic Laboratories, Inc. | |
| Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR | NCT00240682 | Skin Diseases Carcinoma, Squa... | cetuximab | 18 Years - | Centre Hospitalier of Chartres | |
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | NCT00753415 | Non-Small Cell ... Breast Cancer Melanoma Upper GI Tract ... Colon Carcinoma Renal Cell Carc... Bladder Carcino... Prostate Cancer | V935 V934-EP | 18 Years - | Merck Sharp & Dohme LLC | |
| Cantharidin and Occlusion in Verruca Epithelium | NCT03487549 | Common Wart Warts Hand Warts Papillomavirus ... DNA Virus Infec... Skin Diseases, ... Skin Diseases, ... Skin Diseases Virus Diseases Tumor Virus Inf... Verruca Vulgari... Verruca | VP-102 Canthari... VP-102 Canthari... | 2 Years - | Verrica Pharmaceuticals Inc. | |
| An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis | NCT01743560 | Oestrogen Recep... | RAD001 Exemestane | 18 Years - | Novartis | |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
| Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy | NCT03924011 | Radiodermatitis Breast Cancer | Photobiomodulat... Sham laser | 18 Years - | Hasselt University | |
| CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial | NCT00847912 | Carcinoma, Basa... Carcinoma, Squa... Skin Neoplasms Skin Diseases Neoplasms, Basa... Neoplasms, Squa... Carcinoma | 5-fluorouracil Placebo, vehicl... | - | VA Office of Research and Development |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
